It finally happened. After thirteen years we sold a position at a loss in our High Net Worth Portfolios. This summer we sold our investment in Nokia Corp. below cost.... Read More

In November last year, lenders to BioFuel Energy Corp. (NASDAQ:BIOF) exercised their rights under the existing senior secured credit facility acquired the companies ethanol plants and completed their sale to... Read More

All four of the Tweedy Browne Funds made financial progress in the first quarter as global equities, particularly European equities, surged forward after the year-end turbulence associated with the... Read More

Valeant Pharmaceuticals Int (NYSE:VRX) (TSE:VRX) announced on Labor Day, a deal to acquire Medicis Pharmaceutical Corp (NYSE:MRX) in a $2.6 billion deal. The Medicis shareholders would be paid $44 in cash... Read More

Women are more successful at managing alternative investment funds, according to a study from accounting firm Rothstein Kass & Co. From 2007 to 2012, an index of women-owned alternative... Read More

Dan Loeb Q4 2015 letter to investors was finally released. ValueWalk has a full copy which can be seen below (Loeb kept it very short this time). In Dan Loeb's... Read More

Pat Dorsey on if a company's moat withstand bad management? Pat is the author of The Five Rules for Successful Stock Investing and  The Little Book That Builds Wealth. Also see:... Read More

A Battle for Turf Shakes Up the Investment Banking World With Revenue Streams Migrating to New and Diverse Players, Banks Must Look Beyond Traditional Roles and Transform Business Models to... Read More

Talk about costly typos. A mistaken e-mail address typo had placed in jeopardy “highly confidential brokerage account information” of Goldman Sachs Group Inc (NYSE:GS) customers and the investment bank is... Read More

It’s a funny title for a segment, but it is appropriate. I don’t want to be too flippant with dismissals of inflammatory market events like ‘Brexit’ as simply hype.... Read More